Cargando…
The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss
BACKGROUND: Glucose-dependent insulinotropic polypeptide (GIP) appears to have impaired effect on subcutaneous abdominal adipose tissue metabolism in obese subjects. The aim of the present study was to examine whether weight loss may reverse the impaired effect of GIP on subcutaneous abdominal adipo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895376/ https://www.ncbi.nlm.nih.gov/pubmed/27136446 http://dx.doi.org/10.1038/nutd.2016.15 |
_version_ | 1782435834482393088 |
---|---|
author | Asmar, M Arngrim, N Simonsen, L Asmar, A Nordby, P Holst, J J Bülow, J |
author_facet | Asmar, M Arngrim, N Simonsen, L Asmar, A Nordby, P Holst, J J Bülow, J |
author_sort | Asmar, M |
collection | PubMed |
description | BACKGROUND: Glucose-dependent insulinotropic polypeptide (GIP) appears to have impaired effect on subcutaneous abdominal adipose tissue metabolism in obese subjects. The aim of the present study was to examine whether weight loss may reverse the impaired effect of GIP on subcutaneous abdominal adipose tissue in obese subjects. METHODS: Five obese males participated in a 12-week weight loss program, which consisted of caloric restriction (800 Cal day(−)(1)) followed by 4 weeks of weight-maintenance diet. Before and after weight loss, subcutaneous adipose tissue lipid metabolism was studied by conducting regional measurements of arterio-venous plasma concentrations of metabolites and blood flow (adipose tissue blood flow, ATBF) across a segment of the abdominal adipose tissue in the fasting state and during GIP infusion (1.5 pmol kg(−)(1 )min(−)(1)) in combination with a hyperinsulinemic–hyperglycemic clamp. RESULTS: After weight loss (7.5±0.8 kg), glucose tolerance and insulin sensitivity increased significantly as expected. No significant differences were seen in basal ATBF before (1.3±0.4 ml min(−1) 100 g tissue(−1)) and after weight loss (2.1±0.4 ml min(−1) 100 g tissue)(−1); however, a tendency to increase was seen. After weight loss, GIP infusion increased ATBF significantly (3.2±0.1 ml min(−1) 100 g tissue(−1)) whereas there was no increase before weight loss. Triacylglycerol (TAG) uptake did not change after weight loss. Baseline free fatty acid (FFA) and glycerol output increased significantly after weight loss, P<0.001. During the clamp period, FFA and glycerol output declined significantly, P<0.05, with no differences before and after weight loss. Weight loss increased glucose uptake and decreased FFA/glycerol ratio during the clamp period, P<0.05. CONCLUSIONS: In obese subjects, weight loss, induced by calorie restriction, improves the blunted effect of GIP on subcutaneous abdominal adipose tissue metabolism. |
format | Online Article Text |
id | pubmed-4895376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48953762016-06-07 The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss Asmar, M Arngrim, N Simonsen, L Asmar, A Nordby, P Holst, J J Bülow, J Nutr Diabetes Original Article BACKGROUND: Glucose-dependent insulinotropic polypeptide (GIP) appears to have impaired effect on subcutaneous abdominal adipose tissue metabolism in obese subjects. The aim of the present study was to examine whether weight loss may reverse the impaired effect of GIP on subcutaneous abdominal adipose tissue in obese subjects. METHODS: Five obese males participated in a 12-week weight loss program, which consisted of caloric restriction (800 Cal day(−)(1)) followed by 4 weeks of weight-maintenance diet. Before and after weight loss, subcutaneous adipose tissue lipid metabolism was studied by conducting regional measurements of arterio-venous plasma concentrations of metabolites and blood flow (adipose tissue blood flow, ATBF) across a segment of the abdominal adipose tissue in the fasting state and during GIP infusion (1.5 pmol kg(−)(1 )min(−)(1)) in combination with a hyperinsulinemic–hyperglycemic clamp. RESULTS: After weight loss (7.5±0.8 kg), glucose tolerance and insulin sensitivity increased significantly as expected. No significant differences were seen in basal ATBF before (1.3±0.4 ml min(−1) 100 g tissue(−1)) and after weight loss (2.1±0.4 ml min(−1) 100 g tissue)(−1); however, a tendency to increase was seen. After weight loss, GIP infusion increased ATBF significantly (3.2±0.1 ml min(−1) 100 g tissue(−1)) whereas there was no increase before weight loss. Triacylglycerol (TAG) uptake did not change after weight loss. Baseline free fatty acid (FFA) and glycerol output increased significantly after weight loss, P<0.001. During the clamp period, FFA and glycerol output declined significantly, P<0.05, with no differences before and after weight loss. Weight loss increased glucose uptake and decreased FFA/glycerol ratio during the clamp period, P<0.05. CONCLUSIONS: In obese subjects, weight loss, induced by calorie restriction, improves the blunted effect of GIP on subcutaneous abdominal adipose tissue metabolism. Nature Publishing Group 2016-05 2016-05-02 /pmc/articles/PMC4895376/ /pubmed/27136446 http://dx.doi.org/10.1038/nutd.2016.15 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Original Article Asmar, M Arngrim, N Simonsen, L Asmar, A Nordby, P Holst, J J Bülow, J The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss |
title | The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss |
title_full | The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss |
title_fullStr | The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss |
title_full_unstemmed | The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss |
title_short | The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss |
title_sort | blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895376/ https://www.ncbi.nlm.nih.gov/pubmed/27136446 http://dx.doi.org/10.1038/nutd.2016.15 |
work_keys_str_mv | AT asmarm thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT arngrimn thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT simonsenl thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT asmara thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT nordbyp thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT holstjj thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT bulowj thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT asmarm bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT arngrimn bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT simonsenl bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT asmara bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT nordbyp bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT holstjj bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss AT bulowj bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss |